Urgent.News

What's breaking now, across thousands of outlets.

More in Finance & Markets

Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly but still unprofitable.

  • Amgen is a global pharmaceutical giant with operations in 100+ countries
  • Axsome Therapeutics specializes in CNS disorders like depression and narcolepsy
  • Amgen's revenue heavily concentrated in 3 distributors, introducing risk

Olawale Opayinka reveals how Eko Atlantic financial model was built

Founder and Managing Director of Makaya Consult FZE, Olawale Opayinka, has disclosed that he was brought in as far back as 2011 to develop...

  • Olawale Opayinka founded Makaya Consult FZE in 2011.
  • Actuarial scientist quantified uncertainty for Eko Atlantic model.
  • Nigeria's population growth could double Lagos in 15 years.

More from Saturday 29 August →